Case Study: Launching a new molecule for a rare disease

The approach

• Understanding specific needs

  Early on, understand reimbursement landscape, build stakeholder relationships, understand the complex patient journey to support an integrated customized launch.

• Leveraging expertise to coordinate launch needs at each phase

  Deep knowledge of Rare Disease landscape, reimbursement and regulatory across the drug lifecycle to ensure the manufacturer can plan each phase of their launch to optimize commercialization.

• Personalized Patient services

  Rare Disease team dedicated to locating and commercializing patients across the country in timely manner including plan to transition Special Access Program (SAP) patients to the commercial drug once it received an approved Notice of Compliance (NOC).

The outcome

A fully integrated, customized solution & seamless Canadian launch, which avoided potential regulatory delays and effectively supported patients, their families and physicians.

Key insight

A fully integrated service solution offers you access to valuable insights drawn from robust patient data on therapy, physician prescribing, and overall product use across the lifecycle.

At a glance

• Seamless launch of infusion product in rare disease marketplace
• End-to-end solution from importation to commercial drug availability
• Leveraging of our national clinic and nursing footprint
• Expert advice and implementation of reimbursement and regulatory submissions
• Patient and logistics services fully integrated with Innomar patient support solutions